They also displayed reduced expression levels of Oct4 and Nanog and increased expression levels of SSEA1, confirming the study of Ben-Porath et al., reporting that poorly differentiated human tumors overexpressed the pluripotency regulators Oct4, Nanog and sox2, thus linking pluripotency with tumor phenotype [43]. This evidence concerns the gene NANOG and neoplasm.